Imipenem/cilastatin-induced acute eosinophilic pneumonia

BMJ Case Rep. 2016 Mar 4:2016:bcr2016214804. doi: 10.1136/bcr-2016-214804.

Abstract

Drugs, toxins, and infections are known to cause acute eosinophilic pneumonia. Daptomycin and minocycline are the commonly reported antibiotics associated with acute eosinophilic pneumonia. In this study, we present a case of imipenem/cilastatin-induced acute eosinophilic pneumonia. The patient presented with fever, acute hypoxic respiratory distress, and diffuse ground-glass opacities on the chest CT a day after the initiation of imipenem/cilastatin. Patient also developed peripheral eosinophilia. A reinstitution of imipenem/cilastatin resulted in recurrence of the signs and symptoms. A bronchoscopy with bronchoalveolar lavage showed 780 nucleated cells/mm(3) with 15% eosinophil. The patient's clinical condition improved significantly after the discontinuation of imipenem/cilastatin therapy and the treatment with corticosteroid.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Cilastatin / adverse effects*
  • Cilastatin / therapeutic use
  • Cilastatin, Imipenem Drug Combination
  • Drug Combinations
  • Female
  • Humans
  • Imipenem / adverse effects*
  • Imipenem / therapeutic use
  • Middle Aged
  • Pulmonary Eosinophilia / chemically induced
  • Pulmonary Eosinophilia / diagnostic imaging*
  • Pulmonary Eosinophilia / drug therapy
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Drug Combinations
  • Cilastatin
  • Imipenem
  • Cilastatin, Imipenem Drug Combination